Siolta Therapeutics

Siolta Therapeutics

Siolta Therapeutics develops microbiome analyses to test microbial-based therapeutics for the treatment and prevention of inflammatory diseases.

Siolta Therapeutics is a privately held, venture-backed biotechnology company based in San Francisco, California. It focuses on developing therapeutic microbial consortia to prevent and treat inflammatory diseases.

The company's lead product candidate is a therapeutic developed from gut microbiome for the prevention and treatment of allergic asthma. The product is also being explored for the treatment of other allergic conditions such as seasonal allergy, food allergy, and atopic dermatitis. Phase 1 clinical trials are ongoing for these target conditions. Future plans also include the development of therapeutics for other chronic inflammatory diseases.

Timeline

2016

Siolta Therapeutics was founded.

People

Name
Role
LinkedIn

Benjamin M. Fieberger

Scientist

Homer Boushey

Medical Advisor

Jill Bilodeaux

Research Technician

Neeraja Vajrala

Senior Scientist

Nikole Kimes

Co-founder & Chief Scientific Officer

Peter Hutt

Regulatory Advisor

Rene Lopez

Lead Bioinformatics

Samir Kaul

Co-founder

Susan Lynch

Co-founder

Further reading

Title
Author
Link
Type
Date
+ Add new row

Documentaries, videos and podcasts

Title
Date
Link
+ Add new row

Companies

Company
CEO
Location
Products/Services
+ Add new row

References